Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gidal

Showing results (41-50 of 274) with videos related to

Pageof 28
Sort By:
Journal of Child Neurology|August 12, 2006
Optimizing epilepsy management in teenagersRaj D Sheth, Barry E Gidal
Acta Neurologica Scandinavica|May 29, 2012
Vigabatrin-associated retinal damage: potential biochemical mechanismsM K Heim, B E Gidal
International Review of Neurobiology|October 22, 2008
Epilepsy in womenBarry E Gidal, Cynthia L Harden
Epilepsy & Behavior : E&B|September 8, 2020
Seizure clusters, rescue treatments, seizure action plans: Unmet needs and emerging formulationsBarry Gidal, Pavel Klein, Lawrence J Hirsch
Acta Neurologica Scandinavica|May 22, 2015
Antiepileptic drugs in patients with malignant brain tumor: beyond seizures and pharmacokineticsH A Gefroh-Grimes, B E Gidal
Epilepsy Currents|September 21, 2018
Summary of <b>Antiepileptic Drugs</b> Available in the United States of America: WORKING TOWARD A WORLD WITHOUT EPILEPSYDavid G Vossler, Mindl Weingarten, Barry E Gidal, et al.
Epilepsy Research|February 11, 2003
Effects of antiepileptic comedication on levetiracetam pharmacokinetics: a pooled analysis of data from randomized adjunctive therapy trialsE Perucca, B E Gidal, Eugène Baltès
Cleveland Clinic Journal of Medicine|September 24, 2004
Bone disease associated with antiepileptic drugsAlison M Pack, Barry Gidal, Blanca Vazquez
Epilepsy & Behavior : E&B|September 15, 2019
Drug-drug interactions and pharmacodynamics of concomitant clobazam and cannabidiol or stiripentol in refractory seizuresPavel Klein, Dwain Tolbert, Barry E Gidal
Acta Neurologica Scandinavica|May 21, 2020
Changes in perampanel levels during de-induction: Simulations following carbamazepine discontinuationEdgar Schuck, Jim Ferry, Barry Gidal, et al.
Pageof 28

Showing results (41-50 of 274) with videos related to

Sort By:
Pageof 28
Journal of Child Neurology|August 12, 2006
Optimizing epilepsy management in teenagersRaj D Sheth, Barry E Gidal
Acta Neurologica Scandinavica|May 29, 2012
Vigabatrin-associated retinal damage: potential biochemical mechanismsM K Heim, B E Gidal
International Review of Neurobiology|October 22, 2008
Epilepsy in womenBarry E Gidal, Cynthia L Harden
Epilepsy & Behavior : E&B|September 8, 2020
Seizure clusters, rescue treatments, seizure action plans: Unmet needs and emerging formulationsBarry Gidal, Pavel Klein, Lawrence J Hirsch
Acta Neurologica Scandinavica|May 22, 2015
Antiepileptic drugs in patients with malignant brain tumor: beyond seizures and pharmacokineticsH A Gefroh-Grimes, B E Gidal
Epilepsy Currents|September 21, 2018
Summary of <b>Antiepileptic Drugs</b> Available in the United States of America: WORKING TOWARD A WORLD WITHOUT EPILEPSYDavid G Vossler, Mindl Weingarten, Barry E Gidal, et al.
Epilepsy Research|February 11, 2003
Effects of antiepileptic comedication on levetiracetam pharmacokinetics: a pooled analysis of data from randomized adjunctive therapy trialsE Perucca, B E Gidal, Eugène Baltès
Cleveland Clinic Journal of Medicine|September 24, 2004
Bone disease associated with antiepileptic drugsAlison M Pack, Barry Gidal, Blanca Vazquez
Epilepsy & Behavior : E&B|September 15, 2019
Drug-drug interactions and pharmacodynamics of concomitant clobazam and cannabidiol or stiripentol in refractory seizuresPavel Klein, Dwain Tolbert, Barry E Gidal
Acta Neurologica Scandinavica|May 21, 2020
Changes in perampanel levels during de-induction: Simulations following carbamazepine discontinuationEdgar Schuck, Jim Ferry, Barry Gidal, et al.
Pageof 28